Humacyte, Inc. financial data

Symbol
HUMA, HUMAW on Nasdaq
Location
Durham, NC
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 248% % -45%
Quick Ratio 43% %
Debt-to-equity -3163% % -178%
Return On Equity 854% % -27%
Return On Assets -28% % 75%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 187,271,321 shares 49%
Common Stock, Shares, Outstanding 158,835,303 shares 33%
Entity Public Float $453,200,000 USD 154%
Common Stock, Value, Issued $16,000 USD 33%
Weighted Average Number of Shares Outstanding, Basic 158,313,290 shares 33%
Weighted Average Number of Shares Outstanding, Diluted 158,313,290 shares 33%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $753,000 USD
Research and Development Expense $75,353,000 USD -14%
General and Administrative Expense $25,799,000 USD 9.8%
Costs and Expenses $25,143,000 USD -17%
Operating Income (Loss) $105,389,000 USD 6.3%
Nonoperating Income (Expense) $68,420,000 USD
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $36,969,000 USD 76%
Earnings Per Share, Basic 0 USD/shares 83%
Earnings Per Share, Diluted 0 USD/shares 83%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $19,488,000 USD -5.3%
Accounts Receivable, after Allowance for Credit Loss, Current $1,078,000 USD
Inventory, Net $18,418,000 USD
Assets, Current $41,351,000 USD 80%
Property, Plant and Equipment, Net $19,857,000 USD -18%
Operating Lease, Right-of-Use Asset $0 USD
Other Assets, Noncurrent $672,000 USD -48%
Assets $91,509,000 USD -20%
Accounts Payable, Current $9,575,000 USD 39%
Employee-related Liabilities, Current $6,193,000 USD -2.3%
Accrued Liabilities, Current $10,264,000 USD -8%
Liabilities, Current $25,581,000 USD 22%
Deferred Income Tax Liabilities, Net $1,163,000 USD -23%
Operating Lease, Liability, Noncurrent $500,000 USD -17%
Other Liabilities, Noncurrent $520,000 USD -62%
Liabilities $96,260,000 USD -46%
Retained Earnings (Accumulated Deficit) $702,044,000 USD -5.6%
Stockholders' Equity Attributable to Parent $4,751,000 USD 93%
Liabilities and Equity $91,509,000 USD -20%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $28,601,000 USD -4.6%
Net Cash Provided by (Used in) Financing Activities $46,739,000 USD -26%
Net Cash Provided by (Used in) Investing Activities $228,000 USD 42%
Common Stock, Shares Authorized 350,000,000 shares 40%
Common Stock, Shares, Issued 158,835,303 shares 33%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $17,910,000 USD -49%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $19,841,000 USD -72%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD -100%
Deferred Tax Assets, Valuation Allowance $182,867,000 USD 21%
Deferred Tax Assets, Gross $184,030,000 USD 20%
Operating Lease, Liability $0 USD
Depreciation $5,138,000 USD -0.72%
Payments to Acquire Property, Plant, and Equipment $228,000 USD -42%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $36,969,000 USD 76%
Lessee, Operating Lease, Liability, to be Paid $784,000 USD -12%
Property, Plant and Equipment, Gross $59,921,000 USD 0.89%
Operating Lease, Liability, Current $57,000 USD 9.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two $105,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One $105,000 USD 0%
Operating Lease, Weighted Average Discount Rate, Percent 0 pure -106%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $205,000 USD -20%
Lessee, Operating Lease, Liability, to be Paid, Year Three $105,000 USD 0%
Deferred Tax Assets, Operating Loss Carryforwards $97,880,000 USD 21%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $105,000 USD 0%
Additional Paid in Capital $697,277,000 USD 16%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $1,163,000 USD -23%
Share-based Payment Arrangement, Expense $9,125,000 USD 56%
Interest Expense $6,716,000 USD 3.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%